Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason E Drury

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Archives of Biochemistry and Biophysics|June 1, 2007
Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphismsTrevor M Penning, Jason E Drury
Steroids|January 25, 2011
Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)Mo Chen, Jason E Drury, Trevor M Penning
The Journal of Biological Chemistry|June 5, 2010
Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiencyJason E Drury, Rebekka Mindnich, Trevor M Penning
Chemico-Biological Interactions|December 28, 2010
The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme functionRebekka Mindnich, Jason E Drury, Trevor M Penning
The Journal of Biological Chemistry|March 23, 2012
Conversion of human steroid 5β-reductase (AKR1D1) into 3β-hydroxysteroid dehydrogenase by single point mutation E120H: example of perfect enzyme engineeringMo Chen, Jason E Drury, David W Christianson, et al.
The Journal of Biological Chemistry|June 12, 2009
Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complexJason E Drury, Luigi Di Costanzo, Trevor M Penning, et al.
Molecular and Cellular Endocrinology|October 14, 2008
Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1)Luigi Di Costanzo, Jason E Drury, David W Christianson, et al.
The Journal of Biological Chemistry|April 15, 2008
Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysisLuigi Di Costanzo, Jason E Drury, Trevor M Penning, et al.
Molecular Therapy. Methods & Clinical Development|September 30, 2020
Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed BioreactorAlicia D Powers, Jason E Drury, Christopher F Hoehamer, et al.
Protein Engineering, Design & Selection : PEDS|January 11, 2011
Conversion of scFv peptide-binding specificity for crystal chaperone developmentJennifer C Pai, Jeffrey A Culver, Jason E Drury, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Archives of Biochemistry and Biophysics|June 1, 2007
Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphismsTrevor M Penning, Jason E Drury
Steroids|January 25, 2011
Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1)Mo Chen, Jason E Drury, Trevor M Penning
The Journal of Biological Chemistry|June 5, 2010
Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiencyJason E Drury, Rebekka Mindnich, Trevor M Penning
Chemico-Biological Interactions|December 28, 2010
The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme functionRebekka Mindnich, Jason E Drury, Trevor M Penning
The Journal of Biological Chemistry|March 23, 2012
Conversion of human steroid 5β-reductase (AKR1D1) into 3β-hydroxysteroid dehydrogenase by single point mutation E120H: example of perfect enzyme engineeringMo Chen, Jason E Drury, David W Christianson, et al.
The Journal of Biological Chemistry|June 12, 2009
Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complexJason E Drury, Luigi Di Costanzo, Trevor M Penning, et al.
Molecular and Cellular Endocrinology|October 14, 2008
Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1)Luigi Di Costanzo, Jason E Drury, David W Christianson, et al.
The Journal of Biological Chemistry|April 15, 2008
Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysisLuigi Di Costanzo, Jason E Drury, Trevor M Penning, et al.
Molecular Therapy. Methods & Clinical Development|September 30, 2020
Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed BioreactorAlicia D Powers, Jason E Drury, Christopher F Hoehamer, et al.
Protein Engineering, Design & Selection : PEDS|January 11, 2011
Conversion of scFv peptide-binding specificity for crystal chaperone developmentJennifer C Pai, Jeffrey A Culver, Jason E Drury, et al.
Pageof 2